{"title":"Burden and determinants of benign prostate hyperplasia in Africa: Systematic review and meta-analysis","authors":"Kedir Seid , Abel Tibebu Goshu , Sintayehu Samuel Lorato , Mitiku Desalegn , Kelemu Abebe Gelaw , Yohannes Godie Ashebir , Olyad Kuma Getahun , Gebeyehu Lakew , Mathewos Mekonnen Gemmechu , Tiruye Menshaw Tiruneh , Yibeltal Assefa Atalay , Amlaku Nigusie Yirsaw , Eyob Ketema Bogale , Natnael Atnafu Gebeyehu , Tewodros Shitemaw Tekoye , Genanew Kassie Getahun","doi":"10.1016/j.canep.2025.102972","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To determine the prevalence and determinants of benign prostate hyperplasia in Africa via a meta-analysis.</div></div><div><h3>Methods</h3><div>This report was presented according to the Preferred Reporting Items for Systematic Review and Meta-Analyses checklist. Thirteen articles were searched via PubMed/MEDLINE, EMBASE, Scopus, Google Scholar, Science Direct, and African Journal Online. Data were extracted via Microsoft Excel and exported to STATA 17 for analysis. The data were analyzed via the random effects model. The heterogeneity of the studies was assessed by Cochran’s Q test and I<sup>2</sup> statistics. Publication bias was detected via funnel plots and Egger’s test.</div></div><div><h3>Result</h3><div>In 13 studies conducted in Africa, with a sample size of 5619 people between 2011 and 2024, the pooled prevalence of benign prostate hyperplasia was 44 % (95 % CI 31 %-57 %) in Africa. According to the subgroup analysis, the pooled prevalence was greater in studies published from 2011--2018 (56 % (95 % CI: 38--73)) than in those published from 2019--2024 (34 %). The pooled prevalence rates were also greater in those with sample sizes > 500 than in those with sample sizes < 500 (45 % vs 41 %). Family history of BPH (OR = 5.56; 95 % CI; 1<strong>.</strong>57, 9.55), difficulty in sexual activity (OR = 13.14; 95 % CI: 5.50, 20.77), use of traditional eye medication (OR = 2.27; 95 % CI: 1.68, 2.86), family history (OR = 4.93; 95 % CI: 3.13, 6.72) and inadequate sleeping time (OR = 2.90, 95 % CI = 2.25–3.55) were factors associated with benign prostate hyperplasia among adults.</div></div><div><h3>Conclusions</h3><div>The pooled prevalence of BPH among adults living in Africa was significant. Family history, difficulty in sexual activity and inadequate sleeping time were significantly associated with benign prostate hyperplasia. The greater burden of BPH across the country calls for efforts by health policy makers to pay attention to it.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"100 ","pages":"Article 102972"},"PeriodicalIF":3.0000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782125002322","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To determine the prevalence and determinants of benign prostate hyperplasia in Africa via a meta-analysis.
Methods
This report was presented according to the Preferred Reporting Items for Systematic Review and Meta-Analyses checklist. Thirteen articles were searched via PubMed/MEDLINE, EMBASE, Scopus, Google Scholar, Science Direct, and African Journal Online. Data were extracted via Microsoft Excel and exported to STATA 17 for analysis. The data were analyzed via the random effects model. The heterogeneity of the studies was assessed by Cochran’s Q test and I2 statistics. Publication bias was detected via funnel plots and Egger’s test.
Result
In 13 studies conducted in Africa, with a sample size of 5619 people between 2011 and 2024, the pooled prevalence of benign prostate hyperplasia was 44 % (95 % CI 31 %-57 %) in Africa. According to the subgroup analysis, the pooled prevalence was greater in studies published from 2011--2018 (56 % (95 % CI: 38--73)) than in those published from 2019--2024 (34 %). The pooled prevalence rates were also greater in those with sample sizes > 500 than in those with sample sizes < 500 (45 % vs 41 %). Family history of BPH (OR = 5.56; 95 % CI; 1.57, 9.55), difficulty in sexual activity (OR = 13.14; 95 % CI: 5.50, 20.77), use of traditional eye medication (OR = 2.27; 95 % CI: 1.68, 2.86), family history (OR = 4.93; 95 % CI: 3.13, 6.72) and inadequate sleeping time (OR = 2.90, 95 % CI = 2.25–3.55) were factors associated with benign prostate hyperplasia among adults.
Conclusions
The pooled prevalence of BPH among adults living in Africa was significant. Family history, difficulty in sexual activity and inadequate sleeping time were significantly associated with benign prostate hyperplasia. The greater burden of BPH across the country calls for efforts by health policy makers to pay attention to it.
期刊介绍:
Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including:
• Descriptive epidemiology
• Studies of risk factors for disease initiation, development and prognosis
• Screening and early detection
• Prevention and control
• Methodological issues
The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.